Adnan Mir

455 total citations
35 papers, 257 citations indexed

About

Adnan Mir is a scholar working on Dermatology, Epidemiology and Rheumatology. According to data from OpenAlex, Adnan Mir has authored 35 papers receiving a total of 257 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Dermatology, 11 papers in Epidemiology and 8 papers in Rheumatology. Recurrent topics in Adnan Mir's work include Autoimmune Bullous Skin Diseases (5 papers), Drug-Induced Adverse Reactions (4 papers) and Genetic and rare skin diseases. (4 papers). Adnan Mir is often cited by papers focused on Autoimmune Bullous Skin Diseases (5 papers), Drug-Induced Adverse Reactions (4 papers) and Genetic and rare skin diseases. (4 papers). Adnan Mir collaborates with scholars based in United States, United Kingdom and Australia. Adnan Mir's co-authors include S. Meehan, Seth J. Orlow, Nnenna G. Agim, Alex A. Kane, Shellie Josephs, Jason Y. Park, Kathleen Ludwig, Amira Elbendary, Gregory A. Hosler and Mahmoud Nassar and has published in prestigious journals such as SHILAP Revista de lepidopterología, PEDIATRICS and Journal of the American Academy of Dermatology.

In The Last Decade

Adnan Mir

30 papers receiving 252 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adnan Mir United States 10 106 61 47 47 42 35 257
Karima Senouci Morocco 9 100 0.9× 85 1.4× 99 2.1× 20 0.4× 45 1.1× 131 295
Yoo Sang Baek South Korea 9 101 1.0× 61 1.0× 44 0.9× 32 0.7× 16 0.4× 43 301
Talel Badri Tunisia 9 113 1.1× 50 0.8× 61 1.3× 15 0.3× 49 1.2× 73 286
Charles L. Halasz United States 10 113 1.1× 43 0.7× 30 0.6× 63 1.3× 20 0.5× 22 266
Betül Karaatmaca Türkiye 13 57 0.5× 84 1.4× 27 0.6× 29 0.6× 50 1.2× 40 431
Ploysyne Rattanakaemakorn Thailand 10 106 1.0× 56 0.9× 76 1.6× 53 1.1× 11 0.3× 31 363
Omid Zargari Iran 12 113 1.1× 63 1.0× 62 1.3× 42 0.9× 17 0.4× 39 380
Sevgi Akarsu Türkiye 12 223 2.1× 59 1.0× 69 1.5× 32 0.7× 21 0.5× 49 376
P. Unamuno Spain 10 112 1.1× 41 0.7× 52 1.1× 23 0.5× 70 1.7× 26 306
Rashmi Jindal India 9 147 1.4× 32 0.5× 31 0.7× 62 1.3× 13 0.3× 61 290

Countries citing papers authored by Adnan Mir

Since Specialization
Citations

This map shows the geographic impact of Adnan Mir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adnan Mir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adnan Mir more than expected).

Fields of papers citing papers by Adnan Mir

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adnan Mir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adnan Mir. The network helps show where Adnan Mir may publish in the future.

Co-authorship network of co-authors of Adnan Mir

This figure shows the co-authorship network connecting the top 25 collaborators of Adnan Mir. A scholar is included among the top collaborators of Adnan Mir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adnan Mir. Adnan Mir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roy, Simon F., Nnenna G. Agim, Adnan Mir, et al.. (2025). Congenital melanocytic naevi initiated by BRAF fusion oncogene with firmness, pruritus and desmoplastic stroma. British Journal of Dermatology. 193(2). 232–239.
2.
Mir, Adnan, et al.. (2022). Letter in Reply: Alopecia areata after SARS-CoV-2 vaccination. JAAD Case Reports. 25. 25–26. 6 indexed citations
3.
Patel, Parth, et al.. (2022). Erythema multiforme reactions after Pfizer/BioNTech (BNT162b2) and Moderna (mRNA-1273) COVID-19 vaccination: A case series. JAAD Case Reports. 32. 55–58. 6 indexed citations
4.
Khanna, Urmi, et al.. (2022). New diagnosis of systemic lupus erythematosus after COVID-19 vaccination: A case report and review of literature. JAAD Case Reports. 30. 30–34. 8 indexed citations
5.
Mir, Adnan, et al.. (2022). IgA vasculitis triggered by alcohol consumption in a 51-year-old man: A case report. JAAD Case Reports. 24. 18–19.
6.
Nassar, Mahmoud, et al.. (2021). Bullous drug eruption after second dose of mRNA-1273 (Moderna) COVID-19 vaccine: Case report. Journal of Infection and Public Health. 14(10). 1392–1394. 35 indexed citations
7.
Brown, Danielle, Bridget E. Shields, Adnan Mir, et al.. (2021). A cross-sectional study of no-show rates and factors contributing to nonattendance at 3 academic pediatric dermatology centers in the United States. Journal of the American Academy of Dermatology. 86(5). 1169–1172. 7 indexed citations
8.
Deutsch, Alana, Bijal Amin, Adnan Mir, et al.. (2021). Mitomycin extravasation injury: A case series. JAAD Case Reports. 15. 69–72. 5 indexed citations
9.
Mir, Adnan, et al.. (2021). Assessing comfort level with pediatric skin specimens among dermatopathologists and pediatric pathologists: A national cross‐sectional survey. Journal of Cutaneous Pathology. 48(9). 1109–1114. 1 indexed citations
10.
Mir, Adnan, Nnenna G. Agim, Alex A. Kane, et al.. (2019). Giant Congenital Melanocytic Nevus Treated With Trametinib. PEDIATRICS. 143(3). 37 indexed citations
11.
Mir, Adnan, et al.. (2018). High‐risk human papillomavirus in a child with digital pigmented Bowen's disease: Case report and dermoscopic findings. Pediatric Dermatology. 35(5). e265–e267. 2 indexed citations
12.
Ramachandran, Sarika, et al.. (2017). Topical drug-induced subacute cutaneous lupus erythematosus isolated to the hands. Lupus Science & Medicine. 4(1). e000207–e000207. 5 indexed citations
13.
Speiser, Jodi, et al.. (2017). Pernio as the presenting sign of blast crisis in acute lymphoblastic leukemia. Pediatric Dermatology. 35(1). e74–e75. 2 indexed citations
14.
Mir, Adnan, et al.. (2017). Acral Plexiform Palisaded Encapsulated Neuromas as the Initial Cutaneous Manifestation of Cowden Syndrome. Pediatric Dermatology. 34(4). e219–e220. 1 indexed citations
15.
Mir, Adnan, et al.. (2016). Segmental stiff skin syndrome (SSS): A distinct clinical entity. Journal of the American Academy of Dermatology. 75(1). 163–168. 18 indexed citations
16.
Hosler, Gregory A., et al.. (2016). Congenital infantile fibrosarcoma mimicking a cutaneous vascular lesion: a case report and review of the literature. Journal of Cutaneous Pathology. 44(2). 193–200. 15 indexed citations
17.
Mu, Euphemia W., Miguel Sanchez, Adnan Mir, S. Meehan, & Miriam Keltz Pomeranz. (2015). Paraneoplastic erythema annulare centrifugum eruption (PEACE). Dermatology Online Journal. 21(12). 7 indexed citations
18.
Mir, Adnan, et al.. (2013). Cutaneous Features of Crouzon Syndrome With Acanthosis Nigricans. JAMA Dermatology. 149(6). 737–737. 19 indexed citations
19.
Mir, Adnan, Kevin P. Boyd, S. Meehan, & Beth N. McLellan. (2013). Hydroxycholoroquine-induced hyperpigmentation. Dermatology Online Journal. 19(12). 20723–20723. 11 indexed citations
20.
Mir, Adnan, et al.. (2012). Erythema annulare centrifugum. Dermatology Online Journal. 18(12). 21–21. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026